WINKF yields 11695.91% · JNJ yields 2.13%● Live data
📍 WINKF pulled ahead of the other in Year 1
Combined, WINKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WINKF + JNJ for your $10,000?
Windfall Geotek Inc. develops platforms for the mining sector. The company offers computer aided resource detection system, a platform to analyze digital data sets of georeferenced historical exploration data, including geological, geochemical, geophysical, structural, and digital elevation data; and data mining services. It also acquires, explores for, and develops mineral resource properties in Québec. The company has an option agreement to hold 90% undivided interest in the Chapais project that comprises 36 claims located in Quebec; and 95% undivided interest in the Corallen Lake property that comprises 348 claims. It also owns 5,240 claims in the province of Ontario; 1,078 claims in the province of Quebec; and 11 claims in the province of New Brunswick. The company was formerly known as Albert Mining Inc. and changed its name to Windfall Geotek Inc. in October 2019. Windfall Geotek Inc. was incorporated in 1996 and is headquartered in Brossard, Canada.
Full WINKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.